参考文献

1.Lozano R，Naghavi M，Foreman K，et al.Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010：a systematic analysis for the Global Burden of Disease Study 2010.Lancet，2012，380(9859)：2095-2128.

2.Zhong N，Wang C，YaoW，etal.Prevalence of chronic obstructive pulmonary disease in China：a large，population-based survey.Am JRespir Crit Care Med，2007，176：753-760.

3.中华医学会呼吸病学分会慢性阻塞性肺疾病组.慢性阻塞性肺疾病诊治指南(2013年修订版).中华结核和呼吸杂志，2013，36(4)：1-10.

4.Hurst JR，Vestbo J，Anzueto A，et al.Susceptibility to exacerbation in chronic obstructive pulmonary disease.N Engl JMed，2010，363(12)：1128-1138.

5.Hardie JA，Buist AS，Vollmer WM，et al.Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers.Eur Respor J，2002，20(5)：1117-1122.

6.Cerveri I，Corsico AG，Accordini S，et al.Underestimation ofairflow obstruction among young adults using FEV1/FVC<70%as a fixed cutoff：a longitudinal evaluation of clinical and functional outcomes.Thorax，2008，63(12)：1040-1045.

7.Ohlmeier S，Vuolanto M，Toljamo T，et al.Proteomics of human lung tissue identifies surfactant protein A as amarker of chronic obstructive pulmonary disease.J Proteome Res，2008，7(12)：5125-5132.

8.Calabrese F，Baraldo S，Bazzan E，et al.IL-32，a novel proinflammatory cytokine in chronic obstructive pulmonary disease.Am JRespir Crit Care Med，2008，178(9)：894-901.

9.Bridevaux PO，Gerbase MW，Probst-Hensch NM，et al.Long-term decline in lung function，utilisation of care and quality of life inmodified GOLD stage 1 COPD.Thorax，2008，63(9)：768-774.

10.Ofir D，Laveneziana P，Webb KA，et al.Mechanisms of dyspnea during cycle exercise in symptomatic patientswith GOLD stage 1 chronic obstructive pulmonary disease.Am JRespir Crit Care Med，2008，177(6)：622-629.

11.Pitta F，Troosters T，SpruitMA，et al.Characteristics of physical activities in daily life in chronic obstructive pulmonary disease.Am JRespir Crit Care Med，2005，171(9)：972-977.